Manali Shah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Manali Shah has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Adaikalasamy Rosalind Marita
Bayview Advisory Services Pvt. Ltd, Mumbai, India
1 shared publication - Akshay S. Chaudhari
Stanford University
1 shared publication - Anjali Gupta
Stanford University School of Medicine , Stanford, CA
1 shared publication - Anthony J. Saviola
Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado, Aurora, USA
1 shared publication - Clyde Sanvictores
Department of Physics, University of California San Diego, La Jolla, CA 92093, USA
1 shared publication - Emmy Do
Department of Biology, University of California San Diego, La Jolla, CA 92093, USA
1 shared publication
Latest Publications
- 2 August 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 15 (707) , eabj3138
Proregenerative extracellular matrix hydrogel mitigates pathological alterations of pelvic skeletal muscles after birth injury
Pelvic floor disorders, including pelvic organ prolapse and urinary and fecal incontinence, affect millions of women globally and represent a major public health concern. Pelvic floor muscle (PFM) dysfunction has been identified as one of the leading risk factors for the development of these morbid conditions. Childbirth, specifically vaginal delivery, has been recognized as the most important potentially modifiable risk factor for PFM injury; however, the precise mechanisms of PFM dysfunction after parturition remain elusive. In this study, we demonstrated that PFMs exhibit atrophy and fibrosis in parous women with symptomatic pelvic organ prolapse. These pathological alterations were recapitulated in a preclinical rat model of simulated birth injury (SBI). The transcriptional signature of PFMs after injury demonstrated an impairment in muscle anabolism, persistent expression of genes that promote extracellular matrix (ECM) deposition, and a sustained inflammatory response. We also evaluated the administration of acellular injectable skeletal muscle ECM hydrogel for the prevention of these pathological alterations. Treatment of PFMs with the ECM hydrogel either at the time of birth injury or 4 weeks after injury mitigated PFM atrophy and fibrosis. By evaluating gene expression, we demonstrated that these changes are mainly driven by the hydrogel-induced enhancement of endogenous myogenesis, ECM remodeling, and modulation of the immune response. This work furthers our understanding of PFM birth injury and demonstrates proof of concept for future investigations of proregenerative biomaterial approaches for the treatment of injured pelvic soft tissues.
- 2 August 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 15 (707) , eabj3138
Proregenerative extracellular matrix hydrogel mitigates pathological alterations of pelvic skeletal muscles after birth injury
Pelvic floor disorders, including pelvic organ prolapse and urinary and fecal incontinence, affect millions of women globally and represent a major public health concern. Pelvic floor muscle (PFM) dysfunction has been identified as one of the leading risk factors for the development of these morbid conditions. Childbirth, specifically vaginal delivery, has been recognized as the most important potentially modifiable risk factor for PFM injury; however, the precise mechanisms of PFM dysfunction after parturition remain elusive. In this study, we demonstrated that PFMs exhibit atrophy and fibrosis in parous women with symptomatic pelvic organ prolapse. These pathological alterations were recapitulated in a preclinical rat model of simulated birth injury (SBI). The transcriptional signature of PFMs after injury demonstrated an impairment in muscle anabolism, persistent expression of genes that promote extracellular matrix (ECM) deposition, and a sustained inflammatory response. We also evaluated the administration of acellular injectable skeletal muscle ECM hydrogel for the prevention of these pathological alterations. Treatment of PFMs with the ECM hydrogel either at the time of birth injury or 4 weeks after injury mitigated PFM atrophy and fibrosis. By evaluating gene expression, we demonstrated that these changes are mainly driven by the hydrogel-induced enhancement of endogenous myogenesis, ECM remodeling, and modulation of the immune response. This work furthers our understanding of PFM birth injury and demonstrates proof of concept for future investigations of proregenerative biomaterial approaches for the treatment of injured pelvic soft tissues.
- Open Access
- 31 August 2022
- Published by International Journal Of Advanced Research in International Journal of Advanced Research
- Vol. 10 (08) , 1245-1252
A STUDY OF OCULAR MANIFESTATIONS IN HIV/AIDS PATIENTS ATTENDING ART CENTRE AT TERTIARY CARE HOSPITAL OF SOUTH GUJARAT
Introduction:AIDS is a multisystem disease, which can affect any part of the eye& can lead to significant morbidity and mortality. Around 40-70% of patients with HIV infection develops one of the ocular manifestations during lifetime. Introduction of HAART had significantly reduced occurrence of opportunistic infections and neoplasia in these patients. Purpose:This study was conducted to study various ocular manifestations in HIV patients and to find out their prevalence and correlation with CD4 T Cell count. Material & Methods:We conducted a Cross-Sectional Study on 100 confirmed HIV patients taking HAART. We conducted detailed ocular examination of these patients including vision assessment, IOP measurement, slit lamp examination and fundus examination. CD4 T Cell count and Duration of the Disease was also noted. Results:We found 52% prevalence of HIV related ocular manifestations. Anterior Segment manifestations were more common than Posterior Segment. Dry Eye was the most common ocular finding accounting for 44.23% of the patients with ocular manifestations. Other Anterior Segment diseases included Cataract, Conjunctival Microvasculopathy, Blepharitis, Stye, Pterygium, Allergic Conjunctivitis, Anterior Uveitis and Viral Keratitis. Only 7 patients had Posterior Segment Diseases. 1 patient each of CMV Retinitis and PORN was seen, both having CD4 T Cell count below 100 cells/µl. Occurrence of these ocular manifestations were not related to age & gender of the patient or to the duration of the disease. Conclusions:All patients with HIV should undergo Ophthalmic examination, irrespective of the CD4 T Cell count, Duration of Disease or presence of symptoms. Screening help in detecting these ocular diseases at early stage and thereby with early initiation of appropriate treatment help in reducing the visual morbidity.
- 31 August 2022
- Published by International Journal Of Advanced Research in International Journal of Advanced Research
- Vol. 10 (08) , 1245-1252
Open AccessA STUDY OF OCULAR MANIFESTATIONS IN HIV/AIDS PATIENTS ATTENDING ART CENTRE AT TERTIARY CARE HOSPITAL OF SOUTH GUJARAT
Introduction:AIDS is a multisystem disease, which can affect any part of the eye& can lead to significant morbidity and mortality. Around 40-70% of patients with HIV infection develops one of the ocular manifestations during lifetime. Introduction of HAART had significantly reduced occurrence of opportunistic infections and neoplasia in these patients. Purpose:This study was conducted to study various ocular manifestations in HIV patients and to find out their prevalence and correlation with CD4 T Cell count. Material & Methods:We conducted a Cross-Sectional Study on 100 confirmed HIV patients taking HAART. We conducted detailed ocular examination of these patients including vision assessment, IOP measurement, slit lamp examination and fundus examination. CD4 T Cell count and Duration of the Disease was also noted. Results:We found 52% prevalence of HIV related ocular manifestations. Anterior Segment manifestations were more common than Posterior Segment. Dry Eye was the most common ocular finding accounting for 44.23% of the patients with ocular manifestations. Other Anterior Segment diseases included Cataract, Conjunctival Microvasculopathy, Blepharitis, Stye, Pterygium, Allergic Conjunctivitis, Anterior Uveitis and Viral Keratitis. Only 7 patients had Posterior Segment Diseases. 1 patient each of CMV Retinitis and PORN was seen, both having CD4 T Cell count below 100 cells/µl. Occurrence of these ocular manifestations were not related to age & gender of the patient or to the duration of the disease. Conclusions:All patients with HIV should undergo Ophthalmic examination, irrespective of the CD4 T Cell count, Duration of Disease or presence of symptoms. Screening help in detecting these ocular diseases at early stage and thereby with early initiation of appropriate treatment help in reducing the visual morbidity.
- 26 July 2022
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 39 (1) , 124-129
The ‘Insertion/Deletion’ Polymorphism, rs4340 and Diabetes Risk: A Pilot Study from a Hospital Cohort
The insertion/deletion, I/D polymorphism, in the gene encoding Angiotensin Converting Enzyme, ACE is a popular genetic marker for cardiovascular disease, CVD. With alarming rise in diabetes, the risk of CVD among Indian subjects is further enhanced. The present study explored the role of ACE I/D polymorphism, rs4340 as a genetic marker and its association with diabetes. Genomic DNA, isolated from a cohort of 410 urban subjects attending our hospital, was genotyped using polymerase chain reaction followed by electrophoresis. Among the subjects, 84 had type-2 diabetes and 68 had hypertension while 258 were free from these risk factors. Majority (57/84) of diabetic subjects were also suffering from hypertension. Genotype frequencies of ACE I/D polymorphism, of diabetic (84) patients were not different from that of non-diabetic subjects (258). In sharp contrast, we found significant differences, in genotype frequencies of women with diabetes (n = 38) compared to non-diabetic women (70). Diabetic women had significantly higher prevalence of the high risk ‘D’ allele. Analysis of odds ratio, OR revealed that women with ‘D/D’ genotype, exhibited threefold risk (OR 3.12, 95% CI 1.21—8.05; p = 0.018) of diabetes, in the recessive model (D/D vs I/I + I/D). Further when we analysed Odds ratio of diabetic women (8) who were free from hypertension, the results revealed even a greater, 6- fold (OR 6.0, 95% CI 1.29–27.96, p = 0.027) risk of diabetes for D/D homozygous women (D/D vs I/I + I/D). These results suggest ‘sex-specific’ association of ACE ‘I/D’ polymorphism, with type-2 diabetes, affecting women while there was no influence observed among men. In view of the increased cardiovascular mortality among Indians, data from our pilot study if confirmed in a larger cohort, could add value to our future intervention efforts.
- 26 July 2022
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 39 (1) , 124-129
The ‘Insertion/Deletion’ Polymorphism, rs4340 and Diabetes Risk: A Pilot Study from a Hospital Cohort
The insertion/deletion, I/D polymorphism, in the gene encoding Angiotensin Converting Enzyme, ACE is a popular genetic marker for cardiovascular disease, CVD. With alarming rise in diabetes, the risk of CVD among Indian subjects is further enhanced. The present study explored the role of ACE I/D polymorphism, rs4340 as a genetic marker and its association with diabetes. Genomic DNA, isolated from a cohort of 410 urban subjects attending our hospital, was genotyped using polymerase chain reaction followed by electrophoresis. Among the subjects, 84 had type-2 diabetes and 68 had hypertension while 258 were free from these risk factors. Majority (57/84) of diabetic subjects were also suffering from hypertension. Genotype frequencies of ACE I/D polymorphism, of diabetic (84) patients were not different from that of non-diabetic subjects (258). In sharp contrast, we found significant differences, in genotype frequencies of women with diabetes (n = 38) compared to non-diabetic women (70). Diabetic women had significantly higher prevalence of the high risk ‘D’ allele. Analysis of odds ratio, OR revealed that women with ‘D/D’ genotype, exhibited threefold risk (OR 3.12, 95% CI 1.21—8.05; p = 0.018) of diabetes, in the recessive model (D/D vs I/I + I/D). Further when we analysed Odds ratio of diabetic women (8) who were free from hypertension, the results revealed even a greater, 6- fold (OR 6.0, 95% CI 1.29–27.96, p = 0.027) risk of diabetes for D/D homozygous women (D/D vs I/I + I/D). These results suggest ‘sex-specific’ association of ACE ‘I/D’ polymorphism, with type-2 diabetes, affecting women while there was no influence observed among men. In view of the increased cardiovascular mortality among Indians, data from our pilot study if confirmed in a larger cohort, could add value to our future intervention efforts.
- Open Access
- 15 November 2020
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Microbiology Research
- Vol. 7 (3) , 230-236
A descriptive study of vancomycin resistant enterococci in Tertiary Care Hospital of Western India
- 15 November 2020
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Microbiology Research
- Vol. 7 (3) , 230-236
Open AccessA descriptive study of vancomycin resistant enterococci in Tertiary Care Hospital of Western India